Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
Clinical trial NCT00161954 · COMPLETED
Trial details
- NCT number
- NCT00161954
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.